Biograil
Copenhagen
About Biograil
Biograil, founded in 2019 and led by CEO Karsten Lindhardt, is using injection molding to manufacture a device contained in a standard size capsule able to deliver active substances into the gastrointestinal wall. The Biograil device avoids mechanical moving components and makes use of the body’s own peristaltic forces to facilitate the delivery of the biologic efficiently into the gastrointestinal wall.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $3.3M
- Funding stage: Seed
- Last round: Seed (Oct 2022)
- Website: biograil.com
Industries & Categories
Biotechnology, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/biograil-89310 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.